Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2000
09/14/2000WO2000053765A1 Cloning and expression of haemophilus somnus transferrin-binding proteins
09/14/2000WO2000053764A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/14/2000WO2000053763A1 Maize metallothionein gene and promoter
09/14/2000WO2000053762A2 Plant disease resistance associated genes and uses thereof
09/14/2000WO2000053761A2 Human cytokine as ligand of the zalpha receptor and uses thereof
09/14/2000WO2000053760A2 Method of preventing the death of retinal neurons and treating ocular diseases
09/14/2000WO2000053759A1 Expression of human alpha-fetoprotein in mammalian cells
09/14/2000WO2000053758A2 Compositions and methods for the treatment of immune related diseases
09/14/2000WO2000053757A2 Promotion or inhibition of angiogenesis and cardiovascularization
09/14/2000WO2000053756A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/14/2000WO2000053755A2 Compositions and methods for the treatment of tumor
09/14/2000WO2000053754A1 Compositions and methods for the treatment of tumor
09/14/2000WO2000053753A2 Promotion or inhibition of angiogenesis and cardiovascularization
09/14/2000WO2000053752A2 Promotion or inhibition of angiogenesis and cardiovascularization
09/14/2000WO2000053751A1 Methods and compositions for inhibiting neoplastic cell growth
09/14/2000WO2000053750A1 Compositions and methods for the treatment of tumors
09/14/2000WO2000053749A2 Vascular adhesion molecules and modulation of their function
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053741A1 Dna binding proteins that interact with npr1
09/14/2000WO2000053740A1 Method for screening biomolecule activity regulator
09/14/2000WO2000053737A2 Mitomycin biosynthetic gene cluster
09/14/2000WO2000053734A2 Human angiogenesis relevant nucleic acid and protein sequences obtained from endothelial cells
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053730A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
09/14/2000WO2000053729A2 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
09/14/2000WO2000053725A1 Expression of proteolytic enzymes in koji mold in the presence of carbon sources
09/14/2000WO2000053724A2 Compositions and methods for the modification of gene transcription
09/14/2000WO2000053723A2 Scarecrow gene, promoter and uses thereof
09/14/2000WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
09/14/2000WO2000053632A1 Compounds and methods for stimulating gene expression and cellular differentiation
09/14/2000WO2000053631A1 Mammalian cytokines; related reagents and methods
09/14/2000WO2000053630A2 COMPOUNDS THAT DISRUPT MAMMALIAN Rad51 ACTIVITY
09/14/2000WO2000053629A1 Traf-3 deletion isoforms and uses thereof
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053624A1 Chemical synthesis and use of soluble membrane protein receptor domains
09/14/2000WO2000053623A1 Bifunctional molecules for delivery of therapeutics
09/14/2000WO2000053622A1 7tm receptor (axor23)
09/14/2000WO2000053621A2 Synthetic complementary peptides and ophthalmologic uses thereof
09/14/2000WO2000053563A1 Novel ligands of nuclear receptors ppar's
09/14/2000WO2000053229A2 Protein conjugates on the basis of lumazine synthase, methods for producing them and the use thereof
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053219A2 Compositions and methods for treating cancer and hyperproliferative disorders
09/14/2000WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000WO2000053215A2 Deglycosylated ricin toxin a-chain vaccine
09/14/2000WO2000053213A2 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
09/14/2000WO2000053167A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
09/14/2000WO2000053019A1 Dna vaccination for treatment of autoimmune disease
09/14/2000WO2000053007A1 Organ transplant solutions containing conjugates of soluble peptidic compounds with membrane-binding
09/14/2000WO2000053005A1 HETEROGENOUS AND HOMOGENEOUS MOUSE VARIANTS LACKING sno GENE
09/14/2000WO2000053000A1 Plants and feed baits for controlling damage from feeding insects
09/14/2000WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression
09/14/2000WO2000037609A3 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/14/2000WO2000037492A3 Human hepatoma-derived growth factor homologous (huhdgfh) ____
09/14/2000WO2000037488A3 Mads-box genes and uses thereof
09/14/2000WO2000037102A3 Improvement of tolerance to a xenograft
09/14/2000WO2000035480A3 Peptides useful in diagnosing and treating hiv-induced acquired immune deficiency disease
09/14/2000WO2000035430A3 Homer a new target of treating psychiatric disorders
09/14/2000WO2000034496A3 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000031132A8 Novel polypeptide
09/14/2000WO2000030587A3 NF-λB ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES
09/14/2000WO2000028055A3 Hypersensitive response elicitor-induced stress resistance
09/14/2000WO2000027883B1 A method of treating tumors using fas-induced apoptosis
09/14/2000WO2000025818A8 asuE/trmU
09/14/2000WO2000024913A3 Mn gene and protein
09/14/2000WO2000024893A3 Methods and compositions for the prevention and treatment of anemia
09/14/2000WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
09/14/2000WO2000023599A3 Human proteins involved in endoplasmic reticulum protein degradation
09/14/2000WO2000023588B1 G-protein coupled receptors
09/14/2000WO2000022166A3 Genes for assessing cardiovascular status and compositions for use thereof
09/14/2000WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors
09/14/2000WO2000022125A9 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same
09/14/2000WO2000020452A9 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response
09/14/2000WO2000011032A3 Method for producing biostatin (tt-232 triacetate) and analogs thereof
09/14/2000WO1999066875A3 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
09/14/2000WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof
09/14/2000DE19911684A1 Human nucleic acid sequences from endothelial cells useful for treatment of angiogenic disease, including psoriasis, arthritis and diabetic retinopathy, etc
09/14/2000DE19910044A1 Virale Partikel, die nach Infektion durch humanes Cytomegalovirus freigesetzt werden und ihre Verwendung als Impfstoff Viral particles released after infection by human cytomegalovirus and their use as a vaccine
09/14/2000CA2833396A1 Treatment of alpha-galactosidase a deficiency
09/14/2000CA2478736A1 Compositions and methods for the treatment of tumors
09/14/2000CA2478730A1 Compositions and methods for the treatment of tumors
09/14/2000CA2478728A1 Compositions and methods for the treatment of tumors
09/14/2000CA2372164A1 Chemical synthesis and use of soluble membrane protein receptor domains
09/14/2000CA2367334A1 Compositions and methods for the treatment of tumors
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2367313A1 Method for screening biomolecule activity regulator
09/14/2000CA2367073A1 Organ transplant solutions containing conjugates of soluble peptidic compounds with membrane-binding
09/14/2000CA2367067A1 Heterogenous and homogeneous mouse variants lacking sno gene
09/14/2000CA2367060A1 Plants and feed baits for controlling damage from feeding insects
09/14/2000CA2366921A1 Novel cytokine zalpha11 ligand
09/14/2000CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases
09/14/2000CA2366706A1 Mammalian cytokines; related reagents and methods
09/14/2000CA2366689A1 Bifunctional molecules for delivery of therapeutics
09/14/2000CA2366678A1 Synthetic complementary peptides and ophthalmologic uses thereof
09/14/2000CA2366479A1 Compositions and methods for the modification of gene transcription
09/14/2000CA2366427A1 Dna binding proteins that interact with npr1
09/14/2000CA2366281A1 Novel ligands of nuclear receptors ppar's
09/14/2000CA2366147A1 Casb618 polynucleotides and polypeptides and their use
1 ... 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 ... 2916